TC
NVO

TownSquare Capital’s Novo Nordisk NVO Stock Holding History

TownSquare Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$384K Sell
8,005
-77
-1% -$3.31K 0.07% 200
2026
Q1 		$297K Buy
8,082
+1,698
+27% +$80.5K 0.07% 195
2025
Q4 		$325K Sell
6,384
-14,616
-70% -$747K 0.07% 181
2025
Q3 		$1.17M Sell
21,000
-13,141
-38% -$769K 0.18% 119
2025
Q2 		$2.36M Sell
34,141
-264,082
-89% -$18M 0.23% 97
2025
Q1 		$20.7M Sell
298,223
-61,766
-17% -$5.1M 0.22% 87
2024
Q4 		$31M Sell
359,989
-18,784
-5% -$2.03M 0.35% 56
2024
Q3 		$45.1M Sell
378,773
-11,207
-3% -$1.49M 0.54% 33
2024
Q2 		$55.7M Buy
389,980
+46,324
+13% +$6.14M 0.76% 23
2024
Q1 		$44.1M Buy
343,656
+1,456
+0.4% +$173K 0.65% 34
2023
Q4 		$35.4M Sell
342,200
-17,552
-5% -$1.74M 0.61% 35
2023
Q3 		$32.7M Buy
359,752
+110,802
+45% +$9.76M 0.6% 36
2023
Q2 		$20.1M Buy
248,950
+38,610
+18% +$3.15M 0.37% 66
2023
Q1 		$16.7M Sell
210,340
-32,340
-13% -$2.29M 0.37% 64
2022
Q4 		$16.4M Buy
242,680
+5,100
+2% +$299K 0.41% 60
2022
Q3 		$11.8M Buy
237,580
+6,018
+3% +$322K 0.34% 64
2022
Q2 		$12.9M Buy
231,562
+4,650
+2% +$258K 0.37% 60
2022
Q1 		$12.6M Buy
226,912
+19,106
+9% +$981K 0.32% 65
2021
Q4 		$11.6M Buy
207,806
+25,046
+14% +$1.36M 0.29% 72
2021
Q3 		$8.77M Buy
182,760
+2,446
+1% +$118K 0.25% 78
2021
Q2 		$7.67M Buy
180,314
+28,198
+19% +$1.09M 0.25% 79
2021
Q1 		$5.13M Buy
152,116
+990
+0.7% +$35.3K 0.2% 92
2020
Q4 		$5.28M Buy
151,126
+15,726
+12% +$544K 0.23% 85
2020
Q3 		$4.68M Buy
135,400
+20,300
+18% +$677K 0.27% 73
2020
Q2 		$3.75M Buy
115,100
+1,392
+1% +$44.4K 0.25% 79
2020
Q1 		$3.61M Buy
113,708
+28,452
+33% +$847K 0.29% 66
2019
Q4 		$2.47M Buy
85,256
+14,672
+21% +$406K 0.2% 94
2019
Q3 		$1.99M Buy
70,584
+15,500
+28% +$392K 0.16% 108
2019
Q2 		$1.34M Sell
55,084
-113,684
-67% -$2.81M 0.13% 132
2019
Q1 		$4.41M Buy
168,768
+74,282
+79% +$1.83M 0.34% 70
2018
Q4 		$2.31M Buy
+94,486
New +$2.1M 0.3% 69

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

TownSquare Capital's NVO Position: Q2 2026 in Review

TownSquare Capital reduced its Novo Nordisk (NVO) stake by 0.95% in Q2 2026, selling an estimated $3.31K and leaving 8,005 shares worth $384K. The position accounts for 0.07% of the portfolio, ranked #200.

TownSquare Capital first reported a position in NVO in Q4 2018 and has held it in 31 quarters since. The position peaked at $55.7M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • TownSquare Capital held 8,005 shares of Novo Nordisk worth $384K as of Q2 2026.
  • TownSquare Capital sold 77 Novo Nordisk shares in Q2 2026, an estimated $3.31K.
  • Novo Nordisk made up 0.07% of TownSquare Capital's portfolio in Q2 2026, its #200 holding.
  • TownSquare Capital first reported a position in Novo Nordisk in Q4 2018 and has held it in 31 quarters since.
  • TownSquare Capital's Novo Nordisk position peaked at $55.7M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on TownSquare Capital's 13F filing for Q2 2026, filed 14 Aug 2026.